502LBA LBA Orals: Preliminary safety, pharmacokinetics, and antitumor activity of RMC-9805, an oral, RAS(ON) G12D-selective, tri-complex inhibitor in patients with KRAS G12D pancreatic ductal adenocarcinoma (PDAC) from a phase 1 study in advanced solid tumors
Year: 2024
Type: article
Source: European Journal of Cancer
Authors: D.S. Hong, K. Papadopoulos, D.W. Kim, A. Parikh, M. Barve, J. Powderly, A. Starodub, J. Strickler, B.T. Li, P. Oberstein, W. Yu, B. Bitman, S. Lally, W. Lin, S. Sohoni, A. Spira
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4403762576